Healthcare Analytical Testing Services Market Report 2026

The healthcare analytical testing services market size has grown rapidly in recent years. It will grow from $7.6 billion in 2025 to $8.7 billion in 2026 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to increasing pharmaceutical r&d activities, rising complexity of biologic drugs, expansion of contract research services, growing regulatory testing requirements, increased focus on quality assurance.

The healthcare analytical testing services market size is expected to see rapid growth in the next few years. It will grow to $14.64 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to increasing adoption of ai-enabled lab analytics, rising demand for high-throughput testing services, expansion of personalized medicine development, growing focus on rapid microbial detection, increasing outsourcing of analytical validation. Major trends in the forecast period include increasing demand for advanced bioanalytical testing, rising adoption of automated laboratory systems, growing focus on regulatory-compliant validation services, expansion of outsourced analytical testing, enhanced integration of digital laboratory platforms.

The increasing number of clinical trials is expected to drive the growth of the healthcare analytical testing services market. Clinical trials, which involve human participants, are conducted to evaluate the safety and efficacy of medical treatments or interventions. The rising prevalence of chronic and rare diseases is a major factor fueling the growth of clinical trials, as these conditions create increased demand for new and effective treatments. Healthcare analytical testing services are applied in clinical trials to assess drug safety and efficacy, optimize dosing and formulation, ensure data integrity, and maintain quality control. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the number of pharmaceutical industry trials launched in the UK rose for the second consecutive year, increasing from 411 in 2022 to 426 in 2023. Therefore, the growing number of clinical trials is expected to propel the healthcare analytical testing services market.

Major companies in the healthcare analytical testing services market are focusing on innovative offerings, such as broad bioanalytical coverage to support drug development from discovery through late-stage clinical trials, including pharmacokinetic (PK) and pharmacodynamic (PD) assessments. Broad bioanalytical coverage refers to a service’s ability to manage a wide range of testing requirements across multiple molecule types and stages of drug development. For instance, in August 2024, SGS Life Science Services SA, a Switzerland-based contract research organization (CRO) specializing in analytical development and quality control laboratory services, launched a new bioanalytical testing laboratory. The lab measures drugs, their metabolites, and other biologically relevant molecules in biological samples, and additionally provides cell-based assays for cellular biomarkers and sensitive quantification.

In September 2024, Pace Life Sciences, a US-based contract development and manufacturing organization (CDMO), acquired Catalent’s Small Molecule Analytical Services for an undisclosed amount. This acquisition enables Pace to strengthen its capabilities as a full-service analytical outsourcing provider, particularly in supporting clients across early stages of drug research and development through commercialization. Catalent is a US-based provider of analytical services for drug development.

Major companies operating in the healthcare analytical testing services market are Almac Group, ALS Limited, Anacura Life Sciences, Charles River Laboratories International Inc., Element Materials Technology Group, Eurofins Scientific SE, ICON plc, Impact Analytical Testing Lab, Intertek Group plc, Pace Analytical Services LLC, PPD Inc., SourceBio International plc, Steris Corporation, Syneos Health Inc., WuXi AppTec, Analytical Bio-Chemistry Laboratories, Avance Biosciences, Avista Pharma Solutions, Avomeen Analytical Services, BioPharma Services Inc., Boston Analytical, Laboratory Corporation, MedPharm Inc., Micro Quality Labs, Microbac Laboratories, Nelson Laboratories LLC, Pacific Biolabs Inc.

North America was the largest region in the healthcare analytical testing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare analytical testing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the healthcare analytical testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the healthcare analytical testing services market by increasing costs of imported laboratory instruments, reagents, analytical equipment, and digital testing platforms. Pharmaceutical hubs in North America and Europe are most affected due to reliance on imported high-precision instruments, while Asia-Pacific faces cost pressures on contract testing services. These tariffs elevate operational expenses and testing service prices. However, they are also encouraging domestic instrument manufacturing, regional reagent sourcing, and localized laboratory infrastructure investments.

The healthcare analytical testing services market research report is one of a series of new reports that provides healthcare analytical testing services market statistics, including healthcare analytical testing services industry global market size, regional shares, competitors with a healthcare analytical testing services market share, detailed healthcare analytical testing services market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare analytical testing services industry. This healthcare analytical testing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Healthcare analytical testing services refer to the process of validating procedures used in drug discovery and development, assessing finished products, and detecting microorganisms in biological drugs, suspensions, and emulsions.

The primary types of healthcare analytical testing services include bioanalytical testing, physical characterization, method development and validation, raw material testing, batch-release testing, stability testing, microbial testing, and others. Bioanalytical testing services utilize medical devices to evaluate pharmacokinetic and pharmacodynamic parameters and determine the concentration of drugs and metabolites in blood and urine, supporting pharmacological and toxicological research. Bioanalytical testing specifically involves detecting metabolites in biological fluids. Key end-users of these services include pharmaceutical and biopharmaceutical companies, medical device manufacturers, and clinical research organizations.

The healthcare analytical testing services market includes revenues earned by providing services such as environmental monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.